Psychiatry Research: Neuroimaging
Volume 163, Issue 1 , Pages 70-75 , 30 May 2008

Striatal dopaminergic terminals in type 1 and type 2 alcoholics measured with [3H]dihydrotetrabenazine and human whole hemisphere autoradiography

  • Erkki Tupala

      Affiliations

    • Department of Forensic Psychiatry, University of Kuopio, Niuvanniemi Hospital, Kuopio, Finland
    • Department of Pharmacology and Toxicology, P.O. Box 1627, Kuopio, Finland
    • Deceased.
    • ,
  • Merja Häkkinen

      Affiliations

    • Department of Chemistry, University of Kuopio, P.O. Box 1777, Kuopio, Finland
    • ,
  • Markus Storvik

      Affiliations

    • Department of Pharmacology and Toxicology, P.O. Box 1627, Kuopio, Finland
    • Corresponding Author InformationCorresponding author. Department of Pharmacology and Toxicology, University of Kuopio, FI-70210 Kuopio, Finland. Tel.: +358 17 163041; fax: +358 17 162424.
    • ,
  • Jari Tiihonen

      Affiliations

    • Department of Forensic Psychiatry, University of Kuopio, Niuvanniemi Hospital, Kuopio, Finland

Received 9 March 2007 ,Revised 18 July 2007 ,Accepted 3 December 2007.

References 

  1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 3rd ed, revised. Washington, DC: American Psychiatric Press; 1987;
  2. Cloninger CR. The psychobiological regulation of social cooperation. Nature Medicine. 1995;1:623–624
  3. Cohen J. A coefficient of agreement for nominal scales. Educational and psychological measurement. 1960;20:37–46
  4. Da Silva JN, Kilbourn MR, Domino EF. In vivo imaging of monoaminergic nerve terminals in normal and MPTP-lesioned primate brain using positron emission tomography (PET) and [11C]tetrabenazine. Synapse. 1993;14:128–131
  5. Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proceedings of the National Academy of Sciences of the United States of America. 1988;85:5274–5278
  6. Frey K, Kilbourn M, Robinson T. Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine. European Journal of Pharmacology. 1997;334:273–279
  7. Gilman S, Koeppe RA, Adams KM, Junck L, Kluin KJ, Johnson-Greene D, et al. Decreased striatal monoaminergic terminals in severe chronic alcoholism demonstrated with (+) [11C]dihydrotetrabenazine and positron emission tomography. Annals of Neurology. 1998;44:326–333
  8. Landis JR, Koch GG. The measurement of observer agreement for categorial data. Biometrics. 1977;33:159–174
  9. Little KY, Krolewski DM, Zhang L, Cassing BJ. Loss of striatal vesicular monoamine transporter protein (VMAT2) in human cocaine users. American Journal of Psychiatry. 2003;160:47–55
  10. Martinez D, Gil R, Slifstein M, Hwang DR, Huang Y, Perez A, et al. Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biological Psychiatry. 2005;58(10):779–786
  11. Naudon L, Leroux-Nicollete I, Costentin J. Short-term treatments with haloperidol or bromocriptine do not alter the density of the monoamine vesicular transporter in the substantia nigra. Neuroscience Letters. 1994;173:1–4
  12. Repo E, Kuikka JT, Bergström KA, Karhu J, Hiltunen J, Tiihonen J. Dopamine transporter and D2-receptor density in late onset alcoholism. Psychopharmacology. 1999;147:314–318
  13. Schwartz K, Weizman A, Rehavi M. Decreased platelet vesicular monoamine transporter density in habitual smokers. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology. 2005;15:235–238
  14. Schwartz K, Iancu I, Stryjer R, Chelben J, Kotler M, Weizman A, et al. Reduced platelet vesicular monoamine transporter density in smoking schizophrenia patients. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology. 2005;15:557–561
  15. Schwartz K, Nachman R, Yossifoff M, Sapir R, Weizman A, Rehavi M. Cocaine, but not amphetamine, short term treatment elevates the density of rat brain vesicular monoamine transporter 2. Journal of Neural Transmission. 2007;114(4):427–430
  16. Shapiro SS, Wilk MB, Chen HJ. A comparative study of various tests for normality. Journal of the American Statistical Association. 1968;63:1343–1372
  17. Sossi V, Holden JE, Topping GJ, Camborde ML, Kornelsen RA, McCormick SE, et al. In vivo measurement of density and affinity of the monoamine vesicular transport in a unilateral 6-hydroxydopamine rat model in PD. Journal of Cerebral Blood Flow and Metabolism. 2007;27(7):1407–1415
  18. Tiihonen J, Kuikka J, Bergström K, Hakola P, Karhu J, Ryynänen O-P, et al. Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics. Nature Medicine. 1995;1:654–657
  19. Tupala E, Hall H, Särkioja T, Räsänen P, Tiihonen J. Dopamine transporter density in nucleus accumbens of type 1 alcoholics. Lancet. 2000;355:380
  20. Tupala E, Kuikka JT, Hall H, Bergström K, Särkioja T, Räsänen P, et al. Measurement of the striatal dopamine transporter in type 1 alcoholics using human whole hemisphere autoradiography and fractal analysis. NeuroImage. 2001;14:87–94
  21. Tupala E, Hall H, Bergström K, Särkioja T, Räsänen P, Mantere T, et al. Dopamine D2/D3-receptor and transporter densities in nucleus accumbens and amygdala of type 1 and 2 alcoholics. Molecular Psychiatry. 2001;6:261–267
  22. Tupala E, Hall H, Bergström K, Mantere T, Räsänen P, Särkioja T, et al. Dopamine D2 receptors and transporters in type 1 and 2 alcoholics measured with whole hemisphere autoradiography. Human Brain Mapping. 2003;20:91–102
  23. Tupala E, Hall H, Mantere T, Räsänen P, Särkioja T, Tiihonen J. Dopamine receptors and transporters in the brain reward circuits of type 1 and 2 alcoholics measured with whole hemisphere autoradiography. NeuroImage. 2003;19:145–155
  24. van der Borght T, Kilbourn M, Desmond T, Kuhl D, Frey K. The vesicular monoamine transporter is not regulated by dopaminergic drug treatments. European Journal of Pharmacology. 1995;294:577–583
  25. Volkow ND, Wang GJ, Fowler JS, Logan J, Hitzemann R, Ding YS, et al. Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcoholism, Clinical and Experimental Research. 1996;20(9):1594–1598
  26. Yoder KK, Constantinescu CC, Kareken DA, Normandin MD, Cheng TE, O'Connor SJ, et al. Heterogeneous effects of alcohol on dopamine release in the striatum: a PET study. Alcoholism, Clinical and Experimental Research. 2007;31(6):965–973
  27. Zar JH. In: Biostatistical Analysis. 2nd ed.. Englewood Cliffs, NJ: Prentice-Hall Inc.; 1984;p. 310–317
  28. Zucker M, Weizman A, Harel D, Rehavi M. Changes in vesicular monoamine transporter (VMAT2) and synaptophysin in rat substantia nigra and prefrontal cortex induced by psychotropic drugs. Neuropsychobiology. 2001;44(4):187–191

PII: S0925-4927(07)00247-8

doi: 10.1016/j.pscychresns.2007.12.001

Psychiatry Research: Neuroimaging
Volume 163, Issue 1 , Pages 70-75 , 30 May 2008

Article Tools

* Image Usage & Resolution